Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

J&J offers to buy ITCI for $14.6 billion. LLY announces disappointing preliminary sales numbers for the fourth quarter.

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

Johnson amp Johnson JampJ the American multinational pharmaceutical biotechnology and medical technologies corporation agreed to acquire men ...

A man accused of killing his wife and stepson in Henderson was found competent by a judge Wednesday, which means his case ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a neuropsychiatry platform company, announced its first strategic partnership agreement (“SPA”) with Segal Trials as part of its multinational pivotal Phase 3 ...

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, summarized its 2024 accomplishments and detailed upcoming 2025 m ...

Other medication options for late-life GAD ... and serotonin norepinephrine reuptake inhibitors are indicated for generalized anxiety disorder. Cognitive behavioural therapy is a gold standard ...

Questions over the extent to which animals can experience mental illness have existed for centuries. Though researchers and ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...